NCT02476227

Brief Summary

Catheter ablation in the treatment of atrial fibrillation (i.e. pulmonary vein isolation) is now the most effective method of prevention of arrhythmia recurrence. Use of 3D electroanatomical system is now a golden standard. Background hypothesis is that automatic algorithm collecting ablation points during pulmonary vein isolation (with certain catheter stability time, range of motion, and catheter-tissue contact force) prevents forming the gaps in the ablation line, thus preventing pulmonary vein reconnection and AF recurrence. The aim of the trial will be 1:1 comparison of the two methods of pulmonary vein isolation: with manual vs. automatic collection of ablation points using CARTO system and contact force catheter.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P25-P50 for not_applicable atrial-fibrillation

Timeline
Completed

Started Apr 2015

Typical duration for not_applicable atrial-fibrillation

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 5, 2015

Completed
14 days until next milestone

First Posted

Study publicly available on registry

June 19, 2015

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2018

Completed
Last Updated

March 29, 2018

Status Verified

March 1, 2018

Enrollment Period

1.8 years

First QC Date

June 5, 2015

Last Update Submit

March 26, 2018

Conditions

Keywords

atrial fibrillationpulmonary vein isolationRF ablation

Outcome Measures

Primary Outcomes (1)

  • AF recurrence

    Number of AF recurrence after single catheter ablation during 12 months of follow-up.

    1-year follow-up after index procedure

Secondary Outcomes (1)

  • Arrhythmia-free survival

    Time to arrhythmia recurrence, follow-up 3-18 months after index procedure

Study Arms (2)

Visitag group

EXPERIMENTAL

Ablation using CARTO system. Visitag module: automated algorithm to collect RF ablation points using Visitag module. Criteria of ablation point: catheter stability range of motion ≤2.5mm, catheter stability time \>15sec, contact force \>5g over \>50% of time. Optimal contact force suggested: 10-40g.

Procedure: Ablation using CARTO system

Control group

ACTIVE COMPARATOR

Ablation using CARTO system. Manual collection of RF ablation points by operator or by assistant. Optimal contact force suggested: 10-40g.

Procedure: Ablation using CARTO system

Interventions

automated algorithm (Visitag)-based vs. manual collection of RF ablation points during AF ablation

Also known as: RF ablation (CARTO system), Pulmonary vein isolation (CARTO system)
Control groupVisitag group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with symptomatic atrial fibrillation qualified to catheter ablation according to current standards

You may not qualify if:

  • lack of informed consent
  • two previous pulmonary vein isolations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Military Institute of Medicine

Warsaw, 04-141, Poland

Location

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Marek Kiliszek, MD, PhD

    Military Institute of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 5, 2015

First Posted

June 19, 2015

Study Start

April 1, 2015

Primary Completion

January 1, 2017

Study Completion

February 1, 2018

Last Updated

March 29, 2018

Record last verified: 2018-03

Locations